Can statins or other drugs fix cholesterol problems in autoimmune disease?

NCT ID NCT01180361

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study examined why people with rheumatoid arthritis (RA) and lupus have a higher risk of heart attacks. Researchers collected blood samples from 176 participants and tested how statins and adenosine A2A receptor agonists affected cholesterol balance in cells. The goal was to understand whether these drugs could reduce the harmful effects of RA and lupus plasma on cholesterol processing, potentially lowering heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
statins and adenosine A2A receptor agonists
What this could lead to
If successful, this could point toward new ways to lower heart attack risk in people with rheumatoid arthritis or lupus.
What could go wrong
This was a lab-based study, not a treatment trial, so results may not directly translate to patient benefits. The findings are early and exploratory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NYU Langone Hospital - Long Island

    Mineola, New York, 11501, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.